Cancer Cells May Fear Rust More Than Apoptosis
A 2025 review places mitochondria at the center of ferroptosis: four firewalls decide whether cancer cells die by lipid peroxidation. This is a mechanism map, not proof of human benefit.
All articles
Why force falls faster than muscle size: NMJ NaV1.4 loss and ClC-1 inhibition
Human SFEMG and rodent work in JCI 2026 show sarcopenic weakness can come from postsynaptic NaV1.4 loss at the NMJ, not just wasting. Partial ClC-1 inhibition restored transmission-related force in aged rats; this is not a human drug claim.
Beyond Weight Loss — How Semaglutide Quiets the Immune Storm in Your Brain
GLP-1 receptor agonist semaglutide reverses high-fat diet-induced hippocampal microglia activation via the IGFBPL-1/PI3K/AKT pathway in mice. This article explores the molecular bridge from gut hormones to brain protection — and the gap between animal data and clinical reality.
Same Amyloid, Different Deaths: Why Some Neurons Die Harder — and One Death Can Be Blocked with a Drug
## Why does one toxic protein spare some neurons and destroy others? Amyloid-beta, the protein at the heart of Alzheimer's, does not kill every neuron identica
The Brain Under Triple Siege: When Immunity, Blood Sugar, and Blood Vessels All Fail Together
Four 2026 studies converge on one conclusion: brain aging is not the brain's problem alone. Peripheral CD8⁺ EMRA T-cell immunosenescence, plasma glucose with Mendelian Randomization causal evidence, and arterial wall cellular heterogeneity collapse are converging on the aging brain — while intracranial microglia and oligodendrocytes inflammage in near-perfect synchrony (Pearson r≈0.98). Understanding this multi-source siege reframes what prevention might realistically look like.
Contagious Cell Death: How Ferroptosis and Pyroptosis Lock Aging into an Inflammatory Loop
Ferroptosis and pyroptosis are two forms of cell death that rupture and splash pro-inflammatory cargo onto neighboring cells. Four 2026 studies — spanning skin fibroblasts, brain microglia and neurons, and diabetic kidneys — trace the same self-amplifying loop and identify three brake points: HIF-1α, stem-cell-secreted TSG-6, and puerarin's control of caspase-1.
Senescent Cells Get ID Cards: How We Finally Started Counting Them in the Human Body — and Why Wiping Them All Out Is a Bad Idea
Senescent cells have been the bad neighbor of aging biology for nearly two decades. Three 2026 papers flip the question: before we rush to clear them, do we even know what they are? Turns out we barely did — and now that we're learning, the picture is far less black and white.
Viagra for Dementia and the Fiber Myth: The Health Facts You Only Half Understand
A blue pill that might protect your brain, and a fiber classification system that's been misleading you for decades. Two stories about how oversimplified categories can steer us wrong.
Your Genes Help You at 30, Hurt You at 60 — The Time Paradox of Longevity Genes
Recent large-scale genetic analyses shatter the 'longevity gene' myth: the same genetic variant that lowers mortality in youth can increase risk in old age. From antagonistic pleiotropy to circadian rhythms, hippocampal plasticity, and cross-organ aging axes, unpacking the temporal tug-of-war of aging.
If Aging Had a Master Switch: Can SIRT1 Activators Rescue the Aging Brain?
The brain slows and dulls with age. Could a drug flip a single switch and turn that around? A 2026 review puts its bet on SIRT1, the NAD⁺-dependent enzyme whose depletion in the brain is tied to cognitive decline and dementia. Promising, but still far from a human prescription.